Joel Savage en Lifestyle, Communications and journalism, Healthcare Freelance Journalist, writer and author • A MIXTURE OF PERIODICALS 25/11/2016 · 2 min de lectura · +200

THE DEADLY AND SYMPTOM-LESS THREAT OF EBOLA

THE DEADLY AND SYMPTOM-LESS THREAT OF EBOLA

Ebola mutation is still a threat if a patient is declared Ebola free

After Ebola patients declared free of Ebola in the blood, many probably developed a symptom less Ebola Mutation in the central nervous system and separated genetic reproduction center. This Symptom less  Ebola can relapse into contagious Ebola at any time, implicating that potentially ten thousand ticking time bombs walk around in the Mano River Region.

Also it is not impossible that this new form of Ebola could  be contagious without exterior body fluids or even become aerosol in further mutations. If that happens the prediction from W.H.O. and CDC in 2014, that millions of people will die of Ebola in the Mano River  Region will become a self-prophesying reality.  WHY THESE MEDICINES WORK?  Atorvastatin and Irbesartan can treat the dysfunction of the endothelial cells that line the blood vessels, preventing the leakage of fluid from the blood into tissues.

This maintains blood volume, and cuts down  on fluid loss from diarrhea. By maintaining fluid balance, treatment allows patients to live long enough to develop their own immune response to EBOV and other diseases, and they use that response to get rid of  the virus. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMs) Before the Ebola virus enters the cytoplasm in the blood it can be blocked with a specific Selective  Estrogen Receptor Modulator drug (SERM) even before it enters the cell.

According to the US Army  Medical Research Institute of Infectious Diseases, and the University of Virginia, SERM inhibits multiplication of the ebola virus within the cell lessening the burden of infection. 
On 19 June 2013, the FDA approved their application to inhibit Ebola Virus Infection through cell based mechanisms unrelated to the classical estrogen signaling pathing with Selective Estrogen Receptor Modulators specifically the  antiviral activity against the type species Zaire Ebolavirus (EBOV).

The inhabitation occurs after viral  binding and internalization. STATINS .When the Ebola virus already entered a cell, STATINS can block the transport of viruses to cytoplasm of cell volume so they cannot multiply and prevents vascular leakage. One specific substance the Ebola virus requires to move around is the cholesterol transporter Niemann-Pick C1. Researchers discovered that patie